Bristol-Myers Squibb Articles
B-MS makes $185M litigation reserve
30 January 2006
US cancer therapy market to grow 10% pa through 2009
30 January 2006
ImClone up for sale as it returns to profit
30 January 2006
EC allows durable efficacy data for Reyataz label
30 January 2006
Pierre Fabre prepares for succession
30 January 2006
Gilead/B-MS' HIV combo drug is bioequivalant
16 January 2006
Repligen claims patent suit on B-MS' Orencia
16 January 2006
B-MS's arthritis drug Orencia gets FDA go ahead
9 January 2006
B-MS completes submission of dasatinib NDA
9 January 2006
Stock Commentary - New York week to Jan 9
9 January 2006
B-MS completes Orencia sBLA
9 January 2006
Japan stock market 3 weeks to Jan 2, 2006
9 January 2006
B-MS's muraglitazer rights returned
9 January 2006
B-MS announces cost-cutting plans
19 December 2005
Spectrum initiates Ph II satraplatin trials
19 December 2005
Exelixis and B-MS to collborate on Liver X Receptor drugs
12 December 2005
Domantis and B-MS unite on dAb program
12 December 2005
US FDA advisers urge appro of B-MS' Orencia
12 September 2005
B-MS closes sale of US/Canadian consumer business to Novartis
5 September 2005
Novartis bids $4.5B to buy rest of Chiron
5 September 2005
Par receives OK for generic Questran
5 September 2005
ImClone applies to expand Erbitux' indication
5 September 2005
Stock Commentary - New York week to Aug 15
22 August 2005
Gilead's Truvada fails bioequivalence study
22 August 2005
Sankyo's 1st-qtr sales and earnings dip
22 August 2005
USA
22 August 2005
ARV price cuts agreed for Latin America
15 August 2005
US FDA posts DSOB meeting summary
15 August 2005
Gilead's Truvada HIV combo not bioequivalent
15 August 2005
Taiwan acts to curb pharma "overuse"
15 August 2005
Stock Commentary - New York
8 August 2005
Americans OK DTC ban on new drug launches
1 August 2005
B-MS sells OTC business to Novartis
25 July 2005
Teva loses exclusivity on pravastatin, US FDA
18 July 2005
Contract Pharmaceuticals secure deal for B-MS site
11 July 2005
US FDA "tentative OK" for Aurobindo stavudine
11 July 2005
FDA clears Alpharma's Glucovance copy
11 July 2005
Stock Commentary - New York
4 July 2005
Celltrion to make biologicals for B-MS
27 June 2005
Stock Commentary - New York
27 June 2005
Editor's views on corporate and employee health
27 June 2005
ML Labs to buy Quadrant for L46.7M
27 June 2005
B-MS's Muraglitazar shows strong results
20 June 2005
FDA OKs Spectrum's generic carboplatin
20 June 2005
B-MS' Abatacept inhibits RA damage
20 June 2005
B-M Squibb/Merck & Co's Pargluva: good PhI/II
20 June 2005
Stock Commentary - New York
13 June 2005
Icahn plans to up stake in ImClone
13 June 2005
B-MS settles Imclone suit for $89 million
13 June 2005
Codexis and Pfizer enter collaboration
13 June 2005
Codexis and B-MS in research deal
6 June 2005
Medarex' 1st-qtr sales soar, but loss grows
30 May 2005
Statins, the next to go OTC?
30 May 2005
B-MS hosts hep B awareness campaign
23 May 2005
French patent expiries to save1B euros by 2008
23 May 2005
Stock Commentary - New York
16 May 2005
B-MS closes sale of oncology unit
16 May 2005
UK experts back Abilify for schizophrenia
16 May 2005
Elixir licenses GHS from B-MS
16 May 2005
French govt/pharma council: second meeting
9 May 2005
B-MS 1st-qtr 2005 income down 36%
9 May 2005
B-MS settles derivatives litigation
28 April 2005
Together Rx Access ads launched
27 April 2005
Stock Commentary - New York
25 April 2005
Encouraging data for Medarex' cancer drug
25 April 2005
Andrx' metformin ER wins US FDA approval
25 April 2005
Generics threaten maturing statin market; report
18 April 2005
Merck KGaA reports slump in France
11 April 2005
FDA clears B-MS' Baraclude for hep B
11 April 2005
Australian PBS new Rx listings aimed at seniors
11 April 2005
World retail Rx sales up 6% in 12 mnths to Jan
4 April 2005
B-MS prices $2.5B tender offer
4 April 2005
Stock Commentary - New York
4 April 2005
UK guide for industry on Rx access in DCs
4 April 2005
Sanofi-Aventis/B-MS win Plavix patent battle in Canada
28 March 2005
Ex-rep's movie "exposes Rx marketing practices"
28 March 2005
Greek pharma losing private market share
21 March 2005
FDA clears new indication for Abilify
21 March 2005
Greek pharma losing private market share
21 March 2005
South Africa awards ARV drug tenders
14 March 2005
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
